Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-4-19
|
pubmed:abstractText |
Two techniques for labeling of albumin with copper-67 (67Cu) and 62Cu were investigated; one using the native Cu(II) binding site of the protein and the other employing a bifunctional chelate, 6-bromoacetamidobenzyl-1,4,8,11-tetraazacyclotetradecane- N,N'N",N"'-tetraacetic acid (Br-benzyl-TETA or BAT), conjugated to the protein. Rat biodistribution experiments with 67Cu demonstrated retention of i.v. 67Cu-benzyl-TETA-albumin in the blood pool identical to co-injected 125I-albumin. By contrast, i.v. administration of either [67Cu]-Cu-acetate or [67Cu]-Cu-acetate pre-mixed with albumin results in relatively rapid clearance of blood-pool radioactivity as the tracer is excreted into the urine. The 62Cu-benzyl-TETA-albumin radiopharmaceutical was obtained in ca. 17% radiochemical yield (end of synthesis, without decay correction) following a procedure that can be completed in 15-18 min. In PET experiments with a baboon, myocardial blood volume images with 62Cu-benzyl-TETA-albumin were identical to those obtained with C15O. Use of the 62Cu-benzyl-TETA-albumin image for blood-pool subtraction of a 62Cu-PTSM myocardial perfusion image is illustrated. Copper-62-benzyl-TETA-HSA should be a useful, generator-produced radiotracer for the detection of the vascular pool at PET facilities without cyclotrons.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
475-80
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2005455-Animals,
pubmed-meshheading:2005455-Blood Volume Determination,
pubmed-meshheading:2005455-Copper,
pubmed-meshheading:2005455-Female,
pubmed-meshheading:2005455-Heart,
pubmed-meshheading:2005455-Heterocyclic Compounds,
pubmed-meshheading:2005455-Isotope Labeling,
pubmed-meshheading:2005455-Male,
pubmed-meshheading:2005455-Organometallic Compounds,
pubmed-meshheading:2005455-Papio,
pubmed-meshheading:2005455-Rats,
pubmed-meshheading:2005455-Rats, Inbred Strains,
pubmed-meshheading:2005455-Serum Albumin,
pubmed-meshheading:2005455-Tissue Distribution,
pubmed-meshheading:2005455-Tomography, Emission-Computed
|
pubmed:year |
1991
|
pubmed:articleTitle |
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
|
pubmed:affiliation |
Edward Mallinckrodt Institute of Radiology, Department of Internal Medicine, Washington School of Medicine, St. Louis, Missouri.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|